Pfizer Sues Dr. Reddy's Over ANDA For Norvasc Generic

Law360 (February 24, 2004, 12:00 AM EST) -- Pfizer has filed a patent infringement lawsuit in the U.S. Court for the District of New York against Dr. Reddy’s after the Indian generic maker filed an abbreviated new drug application with the U.S. Food and Drug Administration for a copycat version of the hypertension drug Norvasc.

Dr. Reddy's Laboratories filed its ANDA for Amlodipine Besylate tablets 2.5, 5 and 10 mg, with a Paragraph IV certification on the two Orange Book patents listed for the drug.

Amlodipine Besylate is the generic version of Pfizer's Norvasc(R)...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.